08.18.20

DivcoWest Welcomes Bristol Myers Squibb to Cambridge Crossing

Cambridge, MA, (August 18, 2020) – DivcoWest announced today that it has signed a 360,000 square-foot lease with Bristol Myers Squibb (NYSE:BMY) at 250 Water Street in Cambridge Crossing (CX), the new and connected neighborhood at the intersection of Cambridge, Somerville, and Boston. The new building is currently under construction and is expected to be complete in late 2022. Bristol Myers Squibb plans to combine its Cambridge presence at the state-of-the-art laboratory and office building at 250 Water Street by the end of the first half of 2023. Dedicated to helping patients prevail over serious diseases, the biopharmaceutical company will join Philips North America, Sanofi, and Cerevel Therapeutics in the vibrant CX community.

SEE MORE

News

  • The Lexington, Geppetto, and Cafe Beatrice to Open at The Shed in 2020

    Cambridge Crossing // 03.05.20
  • Black History Month: Celebrating the Courage in our Community

    Cambridge Crossing // 02.28.20
  • ‘Tis the Season at CX: Local Spots to Enjoy This Winter Around Cambridge Crossing

    Cambridge Crossing // 12.12.19
  • Cambridge Crossing to Welcome Luminati Spirits X Lamplighter

    Cambridge Crossing // 12.09.19
  • #NationalPhilanthropyDay: How to Give Back This Thanksgiving Season

    Cambridge Crossing // 11.15.19
  • Reflecting Back & Looking Forward: Meaningful Milestones at CX Since Breaking Ground

    Cambridge Crossing // 11.07.19
  • Bringing the Community Together at Cambridge Crossing: CX Summer Nights 2019

    Cambridge Crossing // 10.21.19
  • Making History: Parcel G Concrete Pour

    Cambridge Crossing // 10.10.19
  • Biotech Community Unites at CX For A Great Cause

    LinkedIn // 10.10.19
  • Connecting Cambridge’s Future to its Past: Honoring Harriet Ann Jacobs & Gertrude Wright Morgan

    Cambridge Crossing // 09.12.19